For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she could not make out people’s faces,

Results from a clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

Phase 1/2 trial of Brilliance showed promising results in vision improvement in people with inherited retinal disorders.

An injectable gene therapy caused measurable improvements in vision among a small group of people with inherited blindne

CRISPR gene editing shows potential in treating blindness, with 79% of trial participants experiencing improved vision. About 79% of clinical trial participants experienced measurable improvement after receiving experimental,